Literature DB >> 16567766

Estrogen receptor testing of breast cancer in current clinical practice: what's the question?

Stuart J Schnitt1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16567766     DOI： 10.1200/JCO.2005.05.0666

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  10 in total

1.  Multiplexed assessment of the Southwest Oncology Group-directed Intergroup Breast Cancer Trial S9313 by AQUA shows that both high and low levels of HER2 are associated with poor outcome.

Authors:  Malini Harigopal; William E Barlow; Greg Tedeschi; Peggy L Porter; I-Tien Yeh; Charles Haskell; Robert Livingston; Gabriel N Hortobagyi; George Sledge; Charles Shapiro; James N Ingle; David L Rimm; Daniel F Hayes
Journal:  Am J Pathol       Date:  2010-02-11       Impact factor: 4.307

2.  Bimodal gene expression and biomarker discovery.

Authors:  Adam Ertel
Journal:  Cancer Inform       Date:  2010-02-04

3.  A single-tube quantitative assay for mRNA levels of hormonal and growth factor receptors in breast cancer specimens.

Authors:  Ayuko A Iverson; Cheryl Gillett; Paul Cane; Christopher D Santini; Thomas M Vess; Lauren Kam-Morgan; Alice Wang; Marcia Eisenberg; Charles M Rowland; Janice J Hessling; Samuel E Broder; John J Sninsky; Andrew Tutt; Steven Anderson; Sheng-Yung P Chang
Journal:  J Mol Diagn       Date:  2009-03       Impact factor: 5.568

Review 4.  Prognostic and predictive factors and genetic analysis of early breast cancer.

Authors:  Miguel Martín; Fernando González Palacios; Javier Cortés; Juan de la Haba; José Schneider
Journal:  Clin Transl Oncol       Date:  2009-10       Impact factor: 3.405

5.  Re-Appraisal of Estrogen Receptor Negative/Progesterone Receptor Positive (ER-/PR+) Breast Cancer Phenotype: True Subtype or Technical Artefact?

Authors:  Niamh M Foley; J M Coll; A J Lowery; S O Hynes; M J Kerin; M Sheehan; C Brodie; K J Sweeney
Journal:  Pathol Oncol Res       Date:  2017-09-11       Impact factor: 3.201

6.  Divergent oestrogen receptor-specific breast cancer trends in Ireland (2004-2013): Amassing data from independent Western populations provide etiologic clues.

Authors:  Maeve Mullooly; Jeanne Murphy; Gretchen L Gierach; Paul M Walsh; Sandra Deady; Thomas I Barron; Mark E Sherman; Philip S Rosenberg; William F Anderson
Journal:  Eur J Cancer       Date:  2017-10-23       Impact factor: 9.162

7.  Decreasing Incidence of Estrogen Receptor-Negative Breast Cancer in the United States: Trends by Race and Region.

Authors:  Brittny C Davis Lynn; Pavel Chernyavskiy; Gretchen L Gierach; Philip S Rosenberg
Journal:  J Natl Cancer Inst       Date:  2022-02-07       Impact factor: 11.816

8.  Astronomical algorithms for automated analysis of tissue protein expression in breast cancer.

Authors:  H R Ali; M Irwin; L Morris; S-J Dawson; F M Blows; E Provenzano; B Mahler-Araujo; P D Pharoah; N A Walton; J D Brenton; C Caldas
Journal:  Br J Cancer       Date:  2013-01-17       Impact factor: 7.640

Review 9.  Pharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment.

Authors:  Jürgen Brockmöller; Mladen V Tzvetkov
Journal:  Eur J Clin Pharmacol       Date:  2008-01-26       Impact factor: 2.953

10.  Recent breast cancer trends among Asian/Pacific Islander, Hispanic, and African-American women in the US: changes by tumor subtype.

Authors:  Amelia K Hausauer; Theresa H M Keegan; Ellen T Chang; Christina A Clarke
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.